Table 1. Effect of graded doses of pro-mature BMP15 during IVM on oocyte developmental competence.
Treatments | No. of oocytes | Cleavage (%) | Blastocyst day 8 per cleaved (%) |
Control | 151 | 76.5±3.3 | 39.9±2.3a |
Buffer (Imidazole) 500 mM | 159 | 82.2±6.3 | 40.9±4.6a |
BMP15 10 ng/ml | 151 | 87.4±5.1 | 54.0±3.3b |
BMP15 100 ng/ml | 150 | 83.6±4.9 | 55.5±6.0b |
BMP15 200 ng/ml | 156 | 85.8±1.3 | 59.7±4.4b |
Values with different superscripts within a column are statistically different (P<0.05). Data are presented as mean ± SEM of 4 experiment replicates.